已收盘 08-28 16:00:00 美东时间
-0.520
-1.50%
今日重点评级关注:摩根大通:维持Ultragenyx Pharmaceutical"超配"评级,目标价从75美元升至80美元;瑞杰金融:维持英伟达"强力买入"评级,目标价从330美元升至352美元
08-26 08:37
今日重点评级关注:Truist Securities:维持CoreWeave"买入"评级,目标价从155美元升至165美元;百德:维持亚德诺"跑赢大市"评级,目标价从450美元升至675美元
08-25 11:47
Investment firm Needham said on Monday that it is positive on Zoom Communications (ZM) ahead of its upcoming second-quarter results, set to be released on Aug. 25. “For ZM, we believe Zoom Phone an...
08-25 02:32
Canaccord Genuity analyst David Hynes maintains Five9 (NASDAQ:FIVN) with a Buy and raises the price target from $33 to $39.
08-25 01:26
Two Harbors Investment (TWO) announced it received the final regulatory approval for its planned sale to CrossCountry Mortgage. The deal is expected to close before the market opens on Tuesday, accord...
08-22 04:48
Several infrastructure software names have rallied over the past few months, due in part to AI-related tailwinds, prompting Truist Securities to increase several price targets. "During earnings, JFrog...
08-21 00:12
KeyBanc分析师认为,在上周有报道称银湖资本正就收购Workday进行谈判之后,HubSpot、Five9、阿莎娜、Netskope以及GitLab等公司有望成为下一批潜在的收购对象。
08-19 10:32
HubSpot (HUBS), Five9 (FIVN), Asana (ASAN), Netskope (NTSK), and GitLab (GTLB) may be potential takeover targets after last week's report that Silver Lake was in talks to acquire Workday (WDAY), accor...
08-19 00:39
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24